Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,946 | -22,386 | -16,673 | -12,250 | -17,401 |
| Depreciation Amortization | 96 | 445 | 300 | 223 | 146 |
| Accounts receivable | N/A | N/A | N/A | -450 | N/A |
| Other Working Capital | -419 | -6,041 | -4,682 | -5,941 | -1,438 |
| Other Operating Activity | 1,031 | 7,207 | 6,537 | 6,448 | 12,521 |
| Operating Cash Flow | $-6,238 | $-20,775 | $-14,518 | $-11,970 | $-6,172 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -7,715 | -817 | 237 | -1,094 | 3,531 |
| PPE Investments | -818 | -37 | -7 | 20 | 27 |
| Purchase Sale Intangibles | N/A | N/A | -7 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -7 | 0 | 0 |
| Investing Cash Flow | $-8,533 | $-854 | $223 | $-1,074 | $3,558 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,000 | 4,488 | 3,738 | 3,738 | 3,738 |
| Debt Repayment | -1,100 | -5,542 | -3,292 | -3,292 | -3,292 |
| Common Stock Issued | 15,000 | 38,541 | 35,539 | 18,678 | 15,662 |
| Other Financing Activity | -5,865 | -7,176 | -8,477 | -3,923 | -3,703 |
| Financing Cash Flow | $9,035 | $30,311 | $27,508 | $15,201 | $12,405 |
| Beginning Cash Position | 8,758 | 76 | 76 | 76 | 76 |
| End Cash Position | 3,022 | 8,758 | 13,289 | 2,233 | 9,867 |
| Net Cash Flow | $-5,736 | $8,682 | $13,213 | $2,157 | $9,791 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,238 | -20,775 | -14,518 | -11,970 | -6,172 |
| Capital Expenditure | -818 | -67 | -37 | -10 | -3 |
| Free Cash Flow | -7,056 | -20,842 | -14,555 | -11,980 | -6,175 |